Ignite Creation Date:
2024-05-05 @ 9:47 PM
Last Modification Date:
2024-10-26 @ 10:09 AM
Study NCT ID:
NCT00967811
Status:
COMPLETED
Last Update Posted:
2013-09-19
First Post:
2009-08-27
Brief Title:
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
Sponsor:
Mati Therapeutics Inc
Organization:
Mati Therapeutics Inc
Study Overview
Official Title:
An Open-Label Phase 2 Study of Different Formulations E1 and E2 of the Latanoprost Punctal Plug Delivery System L-PPDS in Subjects With Ocular Hypertension OH or Open-Angle Glaucoma OAG
Status:
COMPLETED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and preliminary efficacy of two formulations of the Latanoprost-PPDS in subjects with ocular hypertension or open-angle glaucoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None